In familial pancreatic cancer (FPC), CDKN2A mutations, along with those in BRCA2 and PALB2, were prevalent, particularly in FPC probands, highlighting their significance in hereditary pancreatic cancer [43]. This evidence concerns the gene PALB2 and familial pancreatic carcinoma.